Status:
ACTIVE_NOT_RECRUITING
Outcomes of Arterial Allografts Preserved at +2 to +8°C for Revascularization in Septic Settings
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Revascularization in a Septic or Potentially Septic Environment
Eligibility:
All Genders
18+ years
Brief Summary
This study does not modify patient management or treatment. All patients undergoing treatment with an arterial allograft preserved at +2/+8°C as part of an arterial revascularization in a septic envir...
Eligibility Criteria
Inclusion
- Adult patient
- Requiring revascularization in a septic or high-risk septic environment
- With an estimated life expectancy of 12 months or more based on medical and surgical assessment
- Informed about the study
Exclusion
- Pregnant women
- Individuals for whom regular medical follow-up cannot be ensured
Key Trial Info
Start Date :
June 3 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06963255
Start Date
June 3 2024
End Date
January 1 2028
Last Update
May 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Bordeaux
Bordeaux, France, 33076
2
HCL hopital Louis Pradel
Bron, France, 69500